BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 14, 2020
View Archived Issues
AbbVie conducts phase Ib study of eftozanermin alfa in relapsed or refractory multiple myeloma
Read More
Enrollment ongoing in phase II study of HTD-1801 in primary biliary cholangitis
Read More
Novel potent PI3Kdelta inhibitors that target two different mechanisms of isoform selectivity
Read More
AK-002 reduces GI eosinophils and symptoms in eosinophilic gastritis/duodenitis: phase I results
Read More
Regenerative approach shows promise in pediatric heart disease
Read More
hAd5-COVID-19 vaccine candidate protects nasal and lung airways in nonhuman primates
Read More
Preliminary clinical data for proxalutamide in COVID-19
Read More
ProTrans-Repeat meets its primary safety endpoint at 24 months
Read More
Leqvio approved in Europe for the treatment of hypercholesterolemia or mixed dyslipidemia
Read More
Tychan to initiate phase III study of TY-027 in patients with COVID-19
Read More
PureTech initiates phase I study of LYT-200 in metastatic solid tumors
Read More
Phase I data presented for CTA-101 in patients with R/R B-cell ALL
Read More
TAK-573 shows clinical activity in relapsed/refractory multiple myeloma in first-in-human study
Read More
Exploratory study suggests ZYN-002 reduces seizures in children with encephalopathies
Read More
Hinova Pharmaceuticals patents new PROTACs
Read More
Cadila Healthcare discloses new compounds for tuberculosis
Read More
Italian researchers identify new compounds for HBV infection
Read More
Boryung Pharmaceutical describes new PI3Kdelta and/or DNA-PK inhibitors
Read More
Suzhou Ribo Life Science patents FXI-targeting siRNA
Read More
MET no better than EMT for cancer metastases
Read More
Amarin reports data on Vascepa in COVID-19 outpatients
Read More
Aerpio announces phase II data on razuprotafib in glaucoma
Read More
Akari releases long-term data on nomacopan in paroxysmal nocturnal hemoglobinuria
Read More
Ultimovacs reports 5-year survival data from phase I trial of UV-1 in metastatic melanoma
Read More
Phase III study of ruxolitinib in COVID-19 does not meet primary endpoint
Read More
PMD-026 shows safety and initial signs of activity in metastatic breast cancer
Read More
